Henry I. Miller

Last updated
Henry Miller
Henry Miller and dog.jpg
Miller in April 2014
Born (1947-07-01) July 1, 1947 (age 77)
Philadelphia, Pennsylvania, U.S.
Occupation(s)Doctor and author

Henry I. Miller (born July 1, 1947) is an American medical researcher and columnist, formerly with the FDA, and from 1994 until 2018 the Robert Wesson Fellow in Scientific Philosophy and Public Policy at Stanford University's Hoover Institution, a public policy think tank located on the university's campus in California. [1] He is an Adjunct Fellow of the Competitive Enterprise Institute.

Contents

Career

He was educated at MIT (B.S. in Life Sciences) and the University of California, San Diego (M.Sc. and M.D.) and was a resident and Clinical Fellow in Medicine [ specify ] at Harvard's Beth Israel Hospital in Boston. He performed research on gene organization and expression as a Research Fellow in the laboratory of Philip Leder M.D. at the National Institutes of Health. [2]

Miller was a civil servant for fifteen years at the US Food and Drug Administration (FDA) (1979–94). He was the medical reviewer for the first genetically engineered drugs to be evaluated by the FDA and was instrumental [3] in the rapid licensing of genetically engineered human insulin and human growth hormone. He was the "medical officer in charge of Humulin [human insulin] at the F.D.A." during its New Drug Application review in 1982. [4] From 1985 to 1989, he was a special assistant to the FDA commissioner and from 1989 to 1993, the founding director of the FDA's Office of Biotechnology. [5]

He has been an Adjunct Fellow at the Competitive Enterprise Institute. [6] He was a trustee of American Council on Science and Health. [7]

In 2017 it was reported that an article published (in 2015) on the Forbes website by Miller, under his own name, had been drafted by Monsanto. [8] As reported by the New York Times, Monsanto asked Miller to write an article rebutting the findings of the International Agency for Research on Cancer that had classified glyphosate as probably carcinogenic to humans. He had indicated willingness “if I could start from a high-quality draft.” [9] On discovering this, Forbes removed his blog from Forbes.com and ended their relationship with him. [9]

Positions

In a 1994 APCO Associates public relations strategy memo to help Phillip Morris organize a global campaign to fight tobacco regulations, Henry Miller was referred to as "a key supporter" and as a potential recruit. [10]

In 2012, in the context of arguing for harm reduction strategies, Miller wrote that "nicotine ... is not particularly bad for you in the amounts delivered by cigarettes or smokeless products. The vast majority of the health risks from tobacco come from the burning and inhalation of smoke. Quitting tobacco altogether remains the ideal outcome, but switching to lower-risk products would be a boon to the health of smokers." [11]

Mehmet Oz

In 2015, Miller coordinated a letter from a group of 10 physicians to Columbia University, demanding that Columbia's College of Physicians and Surgeons remove Mehmet Oz as a professor of surgery, alleging that Oz's public commentary on health issues had "misled and endangered" the public, and claiming that Oz showed "disdain for science and for evidence-based medicine... for personal financial gain." Oz defended his work, said that he lacked conflicts of interest, and questioned the motivations of Miller and his other critics, saying that they had "have big ties to big industry." Columbia defended Oz, citing the principle of academic freedom and faculty members' freedom of expression. [12] [13]

Selected publications

Books

Research articles

Articles and Op-Eds

He is a columnist for Project Syndicate , which translates his articles into as many as 12 languages and submits them to its syndicate of more than 500 newspapers and other publications. [15]

Miller regularly appears on the nationally syndicated radio programs of John Batchelor and Lars Larson. [16]

Awards

Described as a "vocal proponent of the free market", he was shortlisted in 2006 (in the Society and ethics category) by the editors of "Nature Biotechnology" as one of the people who had made the "most significant contributions" to biotechnology during the previous decade. [19]

Related Research Articles

<span class="mw-page-title-main">Aspartame</span> Artificial non-saccharide sweetener

Aspartame is an artificial non-saccharide sweetener 200 times sweeter than sucrose and is commonly used as a sugar substitute in foods and beverages. It is a methyl ester of the aspartic acid/phenylalanine dipeptide with brand names NutraSweet, Equal, and Canderel. Aspartame was approved by the US Food and Drug Administration (FDA) in 1974, and then again in 1981, after approval was revoked in 1980.

<span class="mw-page-title-main">Biotechnology</span> Use of living systems and organisms to develop or make useful products

Biotechnology is a multidisciplinary field that involves the integration of natural sciences and engineering sciences in order to achieve the application of organisms and parts thereof for products and services.

<span class="mw-page-title-main">Genetic engineering</span> Manipulation of an organisms genome

Genetic engineering, also called genetic modification or genetic manipulation, is the modification and manipulation of an organism's genes using technology. It is a set of technologies used to change the genetic makeup of cells, including the transfer of genes within and across species boundaries to produce improved or novel organisms.

The Monsanto Company was an American agrochemical and agricultural biotechnology corporation founded in 1901 and headquartered in Creve Coeur, Missouri. Monsanto's best-known product is Roundup, a glyphosate-based herbicide, developed in the 1970s. Later, the company became a major producer of genetically engineered crops. In 2018, the company ranked 199th on the Fortune 500 of the largest United States corporations by revenue.

<span class="mw-page-title-main">Hoover Institution</span> American political think tank (established 1919)

The Hoover Institution is an American public policy think tank which promotes personal and economic liberty, free enterprise, and limited government. While the institution is formally a unit of Stanford University, it maintains an independent board of overseers and relies on its own income and donations. It is widely described as conservative, although its directors have contested the idea that it is partisan.

<span class="mw-page-title-main">Bovine somatotropin</span> Peptide hormone produced by cows pituitary glands

Bovine somatotropin or bovine somatotrophin, or bovine growth hormone (BGH), is a peptide hormone produced by cows' pituitary glands. Like other hormones, it is produced in small quantities and is used in regulating metabolic processes. Scientists created a bacterium that produces the hormone somatotropin which is produced by the cow's body after giving birth and increases milk production by around 10 percent.

<span class="mw-page-title-main">Recombinant DNA</span> DNA molecules formed by human agency at a molecular level generating novel DNA sequences

Recombinant DNA (rDNA) molecules are DNA molecules formed by laboratory methods of genetic recombination that bring together genetic material from multiple sources, creating sequences that would not otherwise be found in the genome.

Pharming, a portmanteau of farming and pharmaceutical, refers to the use of genetic engineering to insert genes that code for useful pharmaceuticals into host animals or plants that would otherwise not express those genes, thus creating a genetically modified organism (GMO). Pharming is also known as molecular farming, molecular pharming, or biopharming.

<span class="mw-page-title-main">Robert S. Langer</span> American scientist

Robert Samuel Langer Jr. FREng is an American biotechnologist, businessman, chemical engineer, chemist, and inventor. He is one of the nine Institute Professors at the Massachusetts Institute of Technology.

<span class="mw-page-title-main">Genetically modified crops</span> Plants used in agriculture

Genetically modified crops are plants used in agriculture, the DNA of which has been modified using genetic engineering methods. Plant genomes can be engineered by physical methods or by use of Agrobacterium for the delivery of sequences hosted in T-DNA binary vectors. In most cases, the aim is to introduce a new trait to the plant which does not occur naturally in the species. Examples in food crops include resistance to certain pests, diseases, environmental conditions, reduction of spoilage, resistance to chemical treatments, or improving the nutrient profile of the crop. Examples in non-food crops include production of pharmaceutical agents, biofuels, and other industrially useful goods, as well as for bioremediation.

<span class="mw-page-title-main">Genetically modified food controversies</span>

Genetically modified food controversies are disputes over the use of foods and other goods derived from genetically modified crops instead of conventional crops, and other uses of genetic engineering in food production. The disputes involve consumers, farmers, biotechnology companies, governmental regulators, non-governmental organizations, and scientists. The key areas of controversy related to genetically modified food are whether such food should be labeled, the role of government regulators, the objectivity of scientific research and publication, the effect of genetically modified crops on health and the environment, the effect on pesticide resistance, the impact of such crops for farmers, and the role of the crops in feeding the world population. In addition, products derived from GMO organisms play a role in the production of ethanol fuels and pharmaceuticals.

<span class="mw-page-title-main">Bayer</span> German multinational pharmaceutical and biotechnology company

Bayer AG is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include: pharmaceuticals, consumer healthcare products, agricultural chemicals, seeds and biotechnology products. The company is a component of the EURO STOXX 50 stock market index.

Charles Joel Arntzen is a plant molecular biologist. His major contributions are in the field of "plant molecular biology and protein engineering, as well as the utilization of plant biotechnology for enhancement of food quality and value, for expression of pharmacological products in transgenic plants, and for overcoming health and agricultural constraints in the developing world."

<span class="mw-page-title-main">I. Glenn Cohen</span>

I. Glenn Cohen is a Canadian legal scholar and professor at Harvard Law School. He is also the director of Harvard Law School's Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics.

Ultralente insulin was a long-acting form of insulin. It has an onset of 4 to 6 hours, a peak of 14 to 24 hours, and a duration of 28 to 36 hours. Ultralente insulin, along with lente insulin, were discontinued in the US by manufacturers in the mid-2000s. One of the reasons for discontinuation was declining use in favor of NPH insulin and other newer insulin products. The FDA withdrew approval for ultralente insulin products by 2011.

<span class="mw-page-title-main">History of genetic engineering</span>

Genetic engineering is the science of manipulating genetic material of an organism. The concept of genetic engineering was first proposed by Nikolay Timofeev-Ressovsky in 1934. The first artificial genetic modification accomplished using biotechnology was transgenesis, the process of transferring genes from one organism to another, first accomplished by Herbert Boyer and Stanley Cohen in 1973. It was the result of a series of advancements in techniques that allowed the direct modification of the genome. Important advances included the discovery of restriction enzymes and DNA ligases, the ability to design plasmids and technologies like polymerase chain reaction and sequencing. Transformation of the DNA into a host organism was accomplished with the invention of biolistics, Agrobacterium-mediated recombination and microinjection. The first genetically modified animal was a mouse created in 1974 by Rudolf Jaenisch. In 1976, the technology was commercialised, with the advent of genetically modified bacteria that produced somatostatin, followed by insulin in 1978. In 1983, an antibiotic resistant gene was inserted into tobacco, leading to the first genetically engineered plant. Advances followed that allowed scientists to manipulate and add genes to a variety of different organisms and induce a range of different effects. Plants were first commercialized with virus resistant tobacco released in China in 1992. The first genetically modified food was the Flavr Savr tomato marketed in 1994. By 2010, 29 countries had planted commercialized biotech crops. In 2000 a paper published in Science introduced golden rice, the first food developed with increased nutrient value.

<span class="mw-page-title-main">Séralini affair</span> Retracted study led by Gilles-Éric Séralini

The Séralini affair was the controversy surrounding the publication, retraction, and republication of a journal article by French molecular biologist Gilles-Éric Séralini. First published by Food and Chemical Toxicology in September 2012, the article presented a two-year feeding study in rats, and reported an increase in tumors among rats fed genetically modified corn and the herbicide RoundUp. Scientists and regulatory agencies subsequently concluded that the study's design was flawed and its findings unsubstantiated. A chief criticism was that each part of the study had too few rats to obtain statistically useful data, particularly because the strain of rat used, Sprague Dawley, develops tumors at a high rate over its lifetime.

<span class="mw-page-title-main">March Against Monsanto</span> International protest movement

The March Against Monsanto was an international grassroots movement and protest against Monsanto, a producer of genetically modified organisms (GMOs) and Roundup, a glyphosate-based herbicide. The movement was founded by Tami Canal in response to the failure of California Proposition 37, a ballot initiative which would have required labeling food products made from GMOs. Advocates support mandatory labeling laws for food made from GMOs.

<span class="mw-page-title-main">GMO conspiracy theories</span> Conspiracy theories related to GMOs

GMO conspiracy theories are conspiracy theories related to the production and sale of genetically modified crops and genetically modified food. These conspiracy theories include claims that agribusinesses, especially Monsanto, have suppressed data showing that GMOs cause harm, deliberately cause food shortages to promote the use of GM food, or have co-opted government agencies such as the United States Food and Drug Administration or scientific societies such as the American Association for the Advancement of Science.

Chinmoy Sankar Dey is an Indian molecular biologist and a professor at Kusuma School of Biological Sciences of the Indian Institute of Technology, Delhi. Known for his research on insulin resistance, Dey's is a J. C. Bose National Fellow of the Department of Science and Technology and an elected fellow of the National Academy of Sciences, India and the Indian National Science Academy. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 2003. He is also a recipient of the National Bioscience Award for Career Development of the Department of Biotechnology.

References

  1. "Henry I. Miller". The Hoover Institution. July 22, 2014.
  2. "Henry I. Miller". Competitive Enterprise Institute. Retrieved 9 October 2018.
  3. "Henry I. Miller". American Council on Science and Health. Retrieved 9 October 2018.
  4. Altman, Lawrence K. (30 October 1982). "A New Insulin Given Approval for Use in U.S." The New York Times.
  5. "Former Director of the FDA's Office of Biotechnology Pens Op-Ed Criticizing FDA Enforcement on Organic Labeling, FDA Commissioner Pledges to Look at Labeling Claims in Organics". Keller and Heckman LLP. 10 August 2018. Retrieved 9 October 2018.
  6. "Henry I. Miller". Competitive Enterprise Institute. Retrieved 27 October 2014.
  7. "Dr. Oz Audience Down 50 Percent – So We're Halfway There | American Council on Science and Health". Acsh.org. 2015-09-15. Archived from the original on 2015-12-11. Retrieved 2016-04-01.
  8. "Monsanto's Sway Over Research Is Seen in Disclosed Emails". New York Times. 2 August 2017. Retrieved 2 August 2017.
  9. 1 2 Hakim, Danny. (August 1, 2017). "Monsanto Emails Raise Issue of Influencing Research on Roundup Weed Killer", The New York Times . Retrieved August 28, 2018.
  10. Tom Hockaday and Neal Cohen of Apco Associates Inc. Thoughts on TASSC Europe. Memorandum to Matt Winokur, 25 March 1994. Legacy Tobacco Documents Library, University of California, San Francisco. Bates No. 2024233595-2024233602.
  11. Henry I. Miller and Jeff Stier, "The Cigarette Smokescreen." Defining Ideas, March 21, 2012. Hoover.org
  12. Tasneem Nashrulla (April 24, 2015). ""We Will Not Be Silenced:" Dr. Oz Responds To Critics Who Want Him Out Of Columbia". BuzzFeed News.
  13. Elahe Izadi (April 16, 2015). "Dr. Oz responds after prominent physicians call for his firing from Columbia University". Washington Post.
  14. "Barron's 25 Best Books of 2004". seeking alpha.com. 18 December 2004.
  15. "Henry I. Miller". Project Syndicate. Archived from the original on November 13, 2013. Retrieved 2016-04-01.
  16. "Nationally-Renowned Scholar Henry Miller, M.S., M.D., Joins Pacific Research Institute as Senior Fellow in Health Care". 2018. Retrieved 2018-10-09.
  17. "Scientists Honor Top Science Op-Ed Writer: Henry I. Miller". American Council on Science and Health . 7 May 2008. Archived from the original on 14 July 2014. Retrieved 5 July 2014.
  18. Hariri, Robert. "Worldview 100 : worldVIEW". Saworldview.com. Archived from the original on 2016-04-17. Retrieved 2016-04-01.
  19. Sabine Louet (1 March 2006). "Who's Who in Biotech" (PDF). Nature Biotechnology. 24 (3): 291–300. doi:10.1038/nbt0306-291. PMC   7097553 . PMID   16525392. Archived from the original (PDF) on June 6, 2015.